Join
Live feed
·
INSIDERFilingvia Quantisnow
Arbutus Biopharma Corporation logo

Mcelhaugh Michael J. was granted 123,800 shares and sold $23,504 worth of shares (10,164 units at $2.31), increasing direct ownership by 8% to 1,504,793 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.